Revenue-generating with an exciting, diversified, largely externally funded, advanced development pipeline and multiple upcoming catalysts. Recent highlights: Global licensing deal (excluding North America) with Hyloris Pharmaceuticals with RHB-102 for up to $60 million in potential...
Hence then, the article about redhill biopharma announces full year 2024 financial results and operational highlights was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( RedHill Biopharma Announces Full-Year 2024 Financial Results and Operational Highlights )
Also on site :
- Colorado Buffaloes quarterback Dominiq Ponder dies
- DYPB vs CB Dream11 Prediction Today Match, Dream11 Team Today, Fantasy Cricket Tips, Playing XI, Pitch Report, Injury Update- DY Patil T20 Cup 2026, Match 21
- Israel And Hezbollah Exchange Fire As Middle East Conflict Widens